Abstract
Reactive oxygen species (ROS) are metabolic by-products that constitute an indispensable component of physiological processes, albeit their heightened presence may proffer substantial perils to biological entities. Such a proliferation gives rise to a gradual escalation of oxidative stress within the organism, thereby compromising mitochondrial functionality and inflicting harm upon various bodily systems, with a particular predilection for the central nervous system. In its nascent stages, it is plausible that inflammation has been a facilitator in the progression of the malady. The precise role of inflammation in Alzheimer’s disease (AD) remains somewhat enigmatic, although it is conceivable that activated microglia and astrocytes might be implicated in the removal of amyloid-β (Aβ) deposits. Nonetheless, prolonged microglial activation is associated with Tau phosphorylation and Aβ aggregation. Research studies have indicated that AD brains upregulate complementary molecules, inflammatory cytokines, acute phase reacting agents, and other inflammatory mediators that may cause neurodegeneration. In this review, oxidative damage products will be discussed as potential peripheral biomarkers for AD and its early stages. The disordered excretion of pro-inflammatory cytokines, chemokines, oxygen, and nitrogen-reactive species, along with the stimulation of the complement system by glial cells, has the potential to disrupt the functionality of neuronal termini. This perturbation, in turn, culminates in compromised synaptic function, a phenomenon empirically linked to the manifestation of cognitive impairments. The management of neurodegenerative conditions in the context of dementia necessitates therapeutic interventions that specifically target the excessive production of inflammatory and oxidative agents. Furthermore, we shall deliberate upon the function of microglia and oxidative injury in the etiology of AD and the ensuing neurodegenerative processes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
No datasets were generated or analysed during the current study.
References
Adibhatla RM, Hatcher JF (2010) Lipid oxidation and peroxidation in CNS health and disease: from molecular mechanisms to therapeutic opportunities. Antioxid Redox Signal 12(1):125–169. https://doi.org/10.1089/ars.2009.2668
Ahmed N, Ahmed U, Thornalley PJ, Hager K, Fleischer G, Münch G (2005) Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer’s disease and link to cognitive impairment. J Neurochem 92(2):255–263. https://doi.org/10.1111/j.1471-4159.2004.02864.x
Al-Ghraiybah NF, Wang J, Alkhalifa AE, Roberts AB, Raj R, Yang E, Kaddoumi A (2022) Glial cell-mediated neuroinflammation in Alzheimer’s disease. Int J Mol Sci 23(18):10572. https://doi.org/10.3390/ijms231810572
Althafar ZM (2022) Targeting microglia in Alzheimer’s disease: from molecular mechanisms to potential therapeutic targets for small molecules. Molecules 27(13):4124. https://doi.org/10.3390/molecules27134124
Anantharaman M, Tangpong J, Keller JN, Murphy MP, Markesbery WR, Kiningham KK, Clair S, D. K (2006) Β-amyloid mediated nitration of manganese superoxide dismutase. Am J Pathol 168(5):1608–1618. https://doi.org/10.2353/ajpath.2006.051223
Ansari MA, Scheff SW (2010) Oxidative stress in the progression of Alzheimer disease in the frontal cortex. J Neuropathol Exp Neurol 69(2):155–167. https://doi.org/10.1097/nen.0b013e3181cb5af4
Aoyama K (2021) Glutathione in the brain. Int J Mol Sci 22(9):5010. https://doi.org/10.3390/ijms22095010
Ayton S, Portbury S, Kalinowski P, Agarwal P, Diouf I, Schneider JA, Morris MC, Bush AI (2021) Regional brain iron associated with deterioration in Alzheimer’s disease: a large cohort study and theoretical significance. Alzheimer’s Dementia: J Alzheimer’s Association 17(7):1244–1256. https://doi.org/10.1002/alz.12282
Babu A, Urulangodi M (2023) Chemotherapy-induced neuronal DNA damage: an intriguing toolbox to elucidate DNA repair mechanisms in the brain. Genome Instability Disease 4(6):315–332. https://doi.org/10.1007/s42764-023-00110-8
Bailo PS, Martín EL, Calmarza P, Breva SM, Gómez AB, Giráldez AP, Callau JJ, Santamaría JM, Khialani AD, Micó CC, Andreu JC (2022) The role of oxidative stress in neurodegenerative diseases and potential antioxidant therapies. Adv Lab Med 3
Bartolome F, Carro E, Alquezar C (2022) Oxidative stress in tauopathies: from cause to therapy. Antioxid (Basel Switzerland) 11(8):1421. https://doi.org/10.3390/antiox11081421
Berg D, Youdim MBH, Riederer P (2004) Redox imbalance. Cell Tissue Res 318(1):201–213. https://doi.org/10.1007/s00441-004-0976-5
Boateng ID (2023) Ginkgols and bilobols in Ginkgo biloba L. A review of their extraction and bioactivities. Phytother Res 37(8):3211–3223. https://doi.org/10.1002/ptr.7877
Borrajo A, Pérez-Rodríguez D, Fernández-Pereira C, Prieto-González JM, Agís-Balboa RC (2023) Genomic factors and therapeutic approaches in HIV-associated neurocognitive disorders: a comprehensive review. Int J Mol Sci 24(18). https://doi.org/10.3390/ijms241814364
Brown GC, Bal-Price A (2003) Inflammatory neurodegeneration mediated by nitric oxide, glutamate, and mitochondria. Mol Neurobiol 27(3):325–355. https://doi.org/10.1385/mn:27:3:325
Buccellato FR, D’Anca M, Fenoglio C, Scarpini E, Galimberti D (2021a) Role of oxidative damage in Alzheimer’s disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery. Antioxid (Basel Switzerland) 10(9). https://doi.org/10.3390/antiox10091353
Buccellato FR, D’Anca M, Fenoglio C, Scarpini E, Galimberti D (2021b) Role of oxidative damage in Alzheimer’s disease and neurodegeneration: from pathogenic mechanisms to biomarker discovery. Antioxid (Basel Switzerland) 10(9). https://doi.org/10.3390/antiox10091353
Buccellato FR, D’Anca M, Tartaglia GM, Fabbro D, Scarpini M, E., Galimberti D (2023) Treatment of Alzheimer’s disease: beyond symptomatic therapies. Int J Mol Sci 24(18):13900. https://doi.org/10.3390/ijms241813900
Bürklen TS, Schlattner U, Homayouni R, Gough K, Rak M, Szeghalmi A, Wallimann T (2006) The creatine kinase/creatine connection to Alzheimer’s disease: CK inactivation, APP-CK complexes and focal creatine deposits. J Biomed Biotechnol 2006:1–11. https://doi.org/10.1155/jbb/2006/35936
Butterfield DA, Boyd-Kimball D (2018) Oxidative stress, amyloid-β peptide, and altered key molecular pathways in the pathogenesis and progression of Alzheimer’s disease. J Alzheimer’s Disease: JAD 62(3):1345–1367. https://doi.org/10.3233/JAD-170543
Butterfield DA, Reed T, Newman SF, Sultana R (2007) Roles of amyloid β-peptide-associated oxidative stress and brain protein modifications in the pathogenesis of Alzheimer’s disease and mild cognitive impairment. Free Radic Biol Med 43(5):658–677. https://doi.org/10.1016/j.freeradbiomed.2007.05.037
Calou IB, De Barros Viana M, Ribeiro DA, Estadella D, De B, Viana GS (2023) Vitamin D3 (VD3) effects on neuroinflammation and neurodegenerative disorders: focus on Alzheimer’s and Parkinson’s diseases. In Vitamins and Minerals in Neurological Disorders. Academic
Chang K-H, de Pablo Y, Lee H-P, Lee H-G, Smith MA, Shah K (2010) Cdk5 is a major regulator of p38 cascade: relevance to neurotoxicity in Alzheimer’s disease. J Neurochem 113(5):1221–1229. https://doi.org/10.1111/j.1471-4159.2010.06687.x
Chapman MJ, Zamorano JL, Parhofer KG (2022) Reducing residual cardiovascular risk in Europe: therapeutic implications of European medicines agency approval of icosapent ethyl/eicosapentaenoic acid. Pharmacol Ther 237(108172):108172. https://doi.org/10.1016/j.pharmthera.2022.108172
Cheignon C, Tomas M, Bonnefont-Rousselot D, Faller P, Hureau C, Collin F (2018) Oxidative stress and the amyloid beta peptide in Alzheimer’s disease. Redox Biol 14:450–464. https://doi.org/10.1016/j.redox.2017.10.014
Cobb CA, Cole MP (2015) Oxidative and nitrative stress in neurodegeneration. Neurobiol Dis 84:4–21. https://doi.org/10.1016/j.nbd.2015.04.020
Correia SC, Santos RX, Perry G, Zhu X, Moreira PI, Smith MA (2011) Insulin-resistant brain state: the culprit in sporadic Alzheimer’s disease? Ageing Res Rev 10(2):264–273. https://doi.org/10.1016/j.arr.2011.01.001
Cummings J, Lee G, Ritter A, Zhong K (2018) Alzheimer’s disease drug development pipeline: 2018. Alzheimer’s & Dementia (New York, N. Y.) 4(1):195–214. https://doi.org/10.1016/j.trci.2018.03.009
Cummings J, Lee G, Zhong K, Fonseca J, Taghva K (2021) Alzheimer’s disease drug development pipeline: 2021. Alzheimers Dement (N Y) 7(1). https://doi.org/10.1002/trc2.12179
de la Pérez V, Korrapati SV, Pedraza-Chaverrí J (2014) Redox status and aging link in neurodegenerative diseases. Oxid Med Cell Longev 2014:1–2. https://doi.org/10.1155/2014/270291
de Oliveira J, Kucharska E, Garcez ML, Rodrigues MS, Quevedo J, Moreno-Gonzalez I, Budni J (2021) Inflammatory cascade in Alzheimer’s disease pathogenesis: a review of experimental findings. Cells (Basel Switzerland) 10(10):2581. https://doi.org/10.3390/cells10102581
Deora V, Lee JD, Albornoz EA, McAlary L, Jagaraj CJ, Robertson AAB, Atkin JD, Cooper MA, Schroder K, Yerbury JJ, Gordon R, Woodruff TM (2020) The microglial NLRP3 inflammasome is activated by amyotrophic lateral sclerosis proteins. Glia 68(2):407–421. https://doi.org/10.1002/glia.23728
Dodson M, Castro-Portuguez R, Zhang DD (2019) NRF2 plays a critical role in mitigating lipid peroxidation and ferroptosis. Redox Biol 23(101107):101107. https://doi.org/10.1016/j.redox.2019.101107
Erkkinen MG, Kim M-O, Geschwind MD (2018) Clinical neurology and epidemiology of the major neurodegenerative diseases. Cold Spring Harb Perspect Biol 10(4):a033118. https://doi.org/10.1101/cshperspect.a033118
Ferri CP, Prince M, Brayne C, Brodaty H, Fratiglioni L, Ganguli M, Hall K, Hasegawa K, Hendrie H, Huang Y, Jorm A, Mathers C, Menezes PR, Rimmer E, Scazufca M (2005) Global prevalence of dementia: a Delphi consensus study. Lancet 366(9503):2112–2117. https://doi.org/10.1016/s0140-6736(05)67889-0
Fracassi A, Marcatti M, Zolochevska O, Tabor N, Woltjer R, Moreno S, Taglialatela G (2021) Oxidative damage and antioxidant response in frontal cortex of demented and nondemented individuals with Alzheimer’s neuropathology. J Neuroscience: Official J Soc Neurosci 41(3):538–554. https://doi.org/10.1523/JNEUROSCI.0295-20.2020
Fricker M, Tolkovsky AM, Borutaite V, Coleman M, Brown GC (2018) Neuronal cell death. Physiol Rev 98(2):813–880. https://doi.org/10.1152/physrev.00011.2017
Gabbita SP, Robinson KA, Stewart CA, Floyd RA, Hensley K (2000) Redox regulatory mechanisms of cellular signal transduction. Arch Biochem Biophys 376(1):1–13. https://doi.org/10.1006/abbi.1999.1685
García-Escudero V, Martín-Maestro P, Perry G, Avila J (2013) Deconstructing mitochondrial dysfunction in Alzheimer disease. Oxid Med Cell Longev 2013:162152. https://doi.org/10.1155/2013/162152
Garland EF, Hartnell IJ, Boche D (2022) Microglia and astrocyte function and communication: what do we know in humans? Front Neurosci 16. https://doi.org/10.3389/fnins.2022.824888
Gorrini C, Harris IS, Mak TW (2013) Modulation of oxidative stress as an anticancer strategy. Nat Rev Drug Discov 12(12):931–947. https://doi.org/10.1038/nrd4002
Grivennikova VG, Vinogradov AD (2006) Generation of superoxide by the mitochondrial complex I. Biochim et Biophys Acta Bioenergetics 1757(5–6):553–561. https://doi.org/10.1016/j.bbabio.2006.03.013
Grottelli S, Amoroso R, Macchioni L, D’Onofrio F, Fettucciari K, Bellezza I, Maccallini C (2020) Acetamidine-based iNOS inhibitors as molecular tools to counteract inflammation in BV2 microglial cells. Molecules 25(11):2646. https://doi.org/10.3390/molecules25112646
Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E, Cruchaga C, Sassi C, Kauwe JSK, Younkin S, Hazrati L, Collinge J, Pocock J, Lashley T, Williams J, Lambert J-C, Amouyel P, Goate A, Rademakers R, Hardy J (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368(2):117–127. https://doi.org/10.1056/nejmoa1211851
Haddad M, Hervé V, Ben Khedher MR, Rabanel J-M, Ramassamy C (2021) Glutathione: an old and small molecule with great functions and new applications in the brain and in Alzheimer’s disease. Antioxid Redox Signal 35(4):270–292. https://doi.org/10.1089/ars.2020.8129
Hakiminia B, Alikiaii B, Khorvash F, Mousavi S (2022) Oxidative stress and mitochondrial dysfunction following traumatic brain injury: from mechanistic view to targeted therapeutic opportunities. Fundam Clin Pharmacol 36(4):612–662. https://doi.org/10.1111/fcp.12767
Hanslik KL, Ulland TK (2020) The role of microglia and the Nlrp3 inflammasome in Alzheimer’s disease. Front Neurol 11. https://doi.org/10.3389/fneur.2020.570711
Hesse R, Wahler A, Gummert P, Kirschmer S, Otto M, Tumani H, Lewerenz J, Schnack C, von Arnim CAF (2016) Decreased IL-8 levels in CSF and serum of AD patients and negative correlation of MMSE and IL-1β. BMC Neurol 16(1). https://doi.org/10.1186/s12883-016-0707-z
Horiguchi H, Loftus TJ, Hawkins RB, Raymond SL, Stortz JA, Hollen MK, Weiss BP, Miller ES, Bihorac A, Larson SD, Mohr AM, Brakenridge SC, Tsujimoto H, Ueno H, Moore FA, Moldawer LL, Efron PA, & The Sepsis and Critical Illness Research Center Investigators (2018) Innate immunity in the persistent inflammation, immunosuppression, and catabolism syndrome and its implications for therapy. Front Immunol 9. https://doi.org/10.3389/fimmu.2018.00595
Huang Y, Smith DE, Ibáñez-Sandoval O, Sims JE, Friedman WJ (2011) Neuron-specific effects of interleukin-1β are mediated by a novel isoform of the IL-1 receptor accessory protein. J Neuroscience: Official J Soc Neurosci 31(49):18048–18059. https://doi.org/10.1523/jneurosci.4067-11.2011
Ising C, Venegas C, Zhang S, Scheiblich H, Schmidt SV, Vieira-Saecker A, Schwartz S, Albasset S, McManus RM, Tejera D, Griep A, Santarelli F, Brosseron F, Opitz S, Stunden J, Merten M, Kayed R, Golenbock DT, Blum D, Heneka MT (2019) NLRP3 inflammasome activation drives tau pathology. Nature 575(7784):669–673. https://doi.org/10.1038/s41586-019-1769-z
Jadhav SP, Kamath SP, Choolani M, Lu J, Dheen ST (2014) microRNA-200b modulates microglia-mediated neuroinflammation via the cJun/MAPK pathway. J Neurochem 130(3):388–401. https://doi.org/10.1111/jnc.12731
Jellinger KA (2016) A view on early diagnosis of dementias from neuropathology. CRC
** X, Guo J-L, Wang L, Zhong X, Yao W-F, Gao H, Liu M-Y (2021) Natural products as pharmacological modulators of mitochondrial dysfunctions for the treatments of Alzheimer’s disease: a comprehensive review. Eur J Med Chem 218(113401):113401. https://doi.org/10.1016/j.ejmech.2021.113401
Kabir MT, Uddin MS, Zaman S, Begum Y, Ashraf GM, Bin-Jumah MN, Bungau SG, Mousa SA (2021) Abdel-Daim MM. Molecular mechanisms of metal toxicity in the pathogenesis of Alzheimer’s disease. Molecular neurobiology 58:1–20
Kamaruzzaman MA, Romli MH, Abas R, Vidyadaran S, Hidayat Baharuldin MT, Nasaruddin ML, Thirupathirao V, Sura S, Warsito K, Nor M, Azwaruddin NH, Alshawsh MA, M. A., Moklas M (2023) M. A. Regulatory role of the endocannabinoid system on glial cells toward cognitive function in Alzheimer’s disease: a systematic review and meta-analysis of animal studies. Front Pharmacol 14. https://doi.org/10.3389/fphar.2023.1053680
Kany S, Vollrath JT, Relja B (2019) Cytokines in inflammatory disease. Int J Mol Sci 20(23):6008. https://doi.org/10.3390/ijms20236008
Kapfhamer D, Berger KH, Hopf FW, Seif T, Kharazia V, Bonci A, Heberlein U (2010) Protein phosphatase 2A and glycogen synthase kinase 3 signaling modulate prepulse inhibition of the acoustic startle response by altering cortical M-type potassium channel activity. J Neuroscience: Official J Soc Neurosci 30(26):8830–8840. https://doi.org/10.1523/jneurosci.1292-10.2010
Karsten S (2022) Targeting the DNA repair enzymes MTH1 and OGG1 as a novel approach to treat inflammatory diseases. Basic Clin Pharmacol Toxicol 131(2):95–103. https://doi.org/10.1111/bcpt.13765
Katsnelson A, De Strooper B, Zoghbi HY (2016) Neurodegeneration: from cellular concepts to clinical applications. Sci Transl Med 8(364). https://doi.org/10.1126/scitranslmed.aal2074
Kaufmann WE, Sprouse J, Rebowe N, Hanania T, Klamer D, Missling CU (2019) ANAVEX®2–73 (blarcamesine), a Sigma-1 receptor agonist, ameliorates neurologic impairments in a mouse model of Rett syndrome. Pharmacol Biochem Behav 187(172796):172796. https://doi.org/10.1016/j.pbb.2019.172796
Li S, **ao J, Huang C, Sun J (2023) Identification and validation of oxidative stress and immune-related hub genes in Alzheimer’s disease through bioinformatics analysis. Sci Rep 13(1). https://doi.org/10.1038/s41598-023-27977-7
Liddell JR (2017) Are astrocytes the predominant cell type for activation of Nrf2 in aging and neurodegeneration? Antioxid (Basel Switzerland) 6(3):65. https://doi.org/10.3390/antiox6030065
Lippi SLP, Neely CLC, Amaya AL (2022) Trace concentrations, heavy implications: influences of biometals on major brain pathologies of Alzheimer’s disease. Int J Biochem Cell Biol 143(106136):106136. https://doi.org/10.1016/j.biocel.2021.106136
Lismont C, Nordgren M, Van Veldhoven PP, Fransen M (2015) Redox interplay between mitochondria and peroxisomes. Front Cell Dev Biology 3:35. https://doi.org/10.3389/fcell.2015.00035
Liu J-L, Fan Y-G, Yang Z-S, Wang Z-Y, Guo C (2018) Iron and Alzheimer’s disease: from pathogenesis to therapeutic implications. Front Neurosci 12. https://doi.org/10.3389/fnins.2018.00632
Liu H, Gambino F Jr, Algenio CS, Wu C, Gao Y, Bouchard CS, Qiao L, Bu P, Zhao S (2020a) Inflammation and oxidative stress induced by lipid peroxidation metabolite 4-hydroxynonenal in human corneal epithelial cells. Graefe s Archive Clin Experimental Ophthalmol 258(8):1717–1725. https://doi.org/10.1007/s00417-020-04647-2
Liu Z, Yao X, Jiang W, Li W, Zhu S, Liao C, Zou L, Ding R, Chen J (2020b) Advanced oxidation protein products induce microglia-mediated neuroinflammation via MAPKs-NF-κB signaling pathway and pyroptosis after secondary spinal cord injury. J Neuroinflamm 17(1). https://doi.org/10.1186/s12974-020-01751-2
Liu Y, Chen Z, Li B, Yao H, Zarka M, Welch J, Sachdev P, Bridge W, Braidy N (2021) Supplementation with γ-glutamylcysteine (γ-GC) lessens oxidative stress, brain inflammation and amyloid pathology and improves spatial memory in a murine model of AD. Neurochem Int 144(104931):104931. https://doi.org/10.1016/j.neuint.2020.104931
Llanos-González E, Sancho-Bielsa FJ, Frontiñán-Rubio J, Rabanal-Ruíz Y, García-Carpintero S, Chicano E, Úbeda-Banon I, Flores-Cuadrado A, Giménez-Llort L, Alcaín FJ, Peinado JR, Durán-Prado M (2023) Spatial and temporal protein modules signatures associated with Alzheimer disease in 3xTg-AD mice are restored by early ubiquinol supplementation. Antioxid (Basel Switzerland) 12(3). https://doi.org/10.3390/antiox12030747
Lobo A, Launer LJ, Fratiglioni L, Andersen K, Di Carlo A, Breteler MM, Copeland JR, Dartigues JF, Jagger C, Martinez-Lage J, Soininen H, Hofman A (2000) Prevalence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic diseases in the Elderly Research Group. Neurology 54(11 Suppl 5):S4–9
Lopez-Rodriguez AB, Hennessy E, Murray CL, Nazmi A, Delaney HJ, Healy D, Fagan SG, Rooney M, Stewart E, Lewis A, de Barra N, Scarry P, Riggs-Miller L, Boche D, Cunningham MO, Cunningham C (2021) Acute systemic inflammation exacerbates neuroinflammation in Alzheimer’s disease: IL-1β drives amplified responses in primed astrocytes and neuronal network dysfunction. Alzheimer’s & Dementia: The Journal of the Alzheimer’s Association 17(10):1735–755. https://doi.org/10.1002/alz.12341
Mariani E, Polidori MC, Cherubini A, Mecocci P (2005) Oxidative stress in brain aging, neurodegenerative and vascular diseases: an overview. J Chromatogr B Analyt Technol Biomed Life Sci 827(1):65–75. https://doi.org/10.1016/j.jchromb.2005.04.023
Marjani R, Ali Hemati Z, Nemati H, Ahmadi H (2019) The effect of NO system on ethidium bromide-induced oxidative stress in the hippocampal formation of male rats. J Qazvin Univ Med Sci 23(3):190–201
Markesbery WR, Lovell MA (2006) DNA oxidation in Alzheimer’s disease. Antioxid Redox Signal 8(11–12):2039–2045. https://doi.org/10.1089/ars.2006.8.2039
Martínez Leo EE, Segura Campos MR (2019) Systemic oxidative stress: a key point in neurodegeneration — a review. J Nutr Health Aging 23(8):694–699. https://doi.org/10.1007/s12603-019-1240-8
Mazumder S, Bindu S, De R, Debsharma S, Pramanik S, Bandyopadhyay U (2022) Emerging role of mitochondrial DAMPs, aberrant mitochondrial dynamics and anomalous mitophagy in gut mucosal pathogenesis. Life Sci 305(120753):120753. https://doi.org/10.1016/j.lfs.2022.120753
Mehan S, Bhalla S, Siddiqui EM, Sharma N, Shandilya A, Khan A (2022) Potential roles of glucagon-like peptide-1 and its analogues in dementia targeting impaired insulin secretion and neurodegeneration. Degener Neurol Neuromuscul Dis. 31–59
Mehrabadi S, Sadr SS (2020) Administration of vitamin D3 and E supplements reduces neuronal loss and oxidative stress in a model of rats with Alzheimer’s disease. Neurol Res 42(10):862–868. https://doi.org/10.1080/01616412.2020.1787624
Mir RH, Shah AJ, Mohi-ud-din R, Pottoo FH, Dar MA, Jachak SM, Masoodi MH (2021) Natural anti-inflammatory compounds as drug candidates in Alzheimer’s disease. Curr Med Chem 28(23):4799–4825. https://doi.org/10.2174/0929867327666200730213215
Misrani A, Tabassum S, Yang L (2021) Mitochondrial dysfunction and oxidative stress in Alzheimer’s disease. Frontiers Aging Neurosci 13. https://doi.org/10.3389/fnagi.2021.617588
Mittal M, Siddiqui MR, Tran K, Reddy SP, Malik AB (2014) Reactive oxygen species in inflammation and tissue injury. Antioxid Redox Signal 20(7):1126–1167. https://doi.org/10.1089/ars.2012.5149
Mizuno Y, Abolhassani N, Mazzei G, Saito T, Saido TC, Yamasaki R, Kira J-I, Nakabeppu Y (2022) Deficiency of MTH1 and/or OGG1 increases the accumulation of 8-oxoguanine in the brain of the AppNL-G-F/NL-G-F knock-in mouse model of Alzheimer’s disease, accompanied by accelerated microgliosis and reduced anxiety-like behavior. Neurosci Res 177:118–134. https://doi.org/10.1016/j.neures.2021.11.009
Montine TJ, Peskind ER, Quinn JF, Wilson AM, Montine KS, Galasko D (2011) Increased cerebrospinal fluid F2-isoprostanes are associated with aging and latent Alzheimer’s disease as identified by biomarkers. Neuromol Med 13(1):37–43. https://doi.org/10.1007/s12017-010-8126-6
Moorthy R, Bhattamisra SK, Pandey M, Mayuren J, Kow CS, Candasamy M (2024) Mitochondria and diabetes: insights and potential therapies. Expert Rev Endocrinol Metabolism 19(2):141–154. https://doi.org/10.1080/17446651.2024.2307526
Morais FM, Ribeiro AM, Moreira FA, Silva PVG (2021) Systematic review and meta-analysis on the role of mitochondrial cytochrome c oxidase in Alzheimer’s disease. Acta Neuropsychiatrica 33(2):55–64. https://doi.org/10.1017/neu.2020.43
Mortensen MS, Ruiz J, Watts JL (2023) Polyunsaturated fatty acids drive lipid peroxidation during ferroptosis. Cells (Basel Switzerland) 12(5):804. https://doi.org/10.3390/cells12050804
Musazadeh V, Dehghan P, Saleh-Ghadimi S, Abbasalizad Farhangi M (2021) Omega 3-rich Camelina sativa oil in the context of a weight loss program improves glucose homeostasis, inflammation and oxidative stress in patients with NAFLD: a randomised placebo‐controlled clinical trial. Int J Clin Pract 75(11). https://doi.org/10.1111/ijcp.14744
Mussbacher M, Salzmann M, Brostjan C, Hoesel B, Schoergenhofer C, Datler H, Hohensinner P, Basílio J, Petzelbauer P, Assinger A, Schmid JA (2019) Cell type-specific roles of NF-κB linking inflammation and thrombosis. Front Immunol 10:85. https://doi.org/10.3389/fimmu.2019.00085
Nakagawa Y, Chiba K (2014) Role of microglial M1/M2 polarization in relapse and remission of psychiatric disorders and diseases. Pharmaceuticals (Basel Switzerland) 7(12):1028–1048. https://doi.org/10.3390/ph7121028
Nakamura M, Shishido N, Nunomura A, Smith MA, Perry G, Hayashi Y, Nakayama K, Hayashi T (2007) Three histidine residues of amyloid-β peptide control the redox activity of copper and iron. Biochemistry 46(44):12737–12743. https://doi.org/10.1021/bi701079z
Nathan C, Calingasan N, Nezezon J, Ding A, Lucia MS, La Perle K, Fuortes M, Lin M, Ehrt S, Kwon NS, Chen J, Vodovotz Y, Kipiani K, Beal MF (2005) Protection from Alzheimer’s-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med 202(9):1163–1169. https://doi.org/10.1084/jem.20051529
Oka S, Leon J, Sakumi K, Abolhassani N, Sheng Z, Tsuchimoto D, LaFerla FM, Nakabeppu Y (2021) MTH1 and OGG1 maintain a low level of 8-oxoguanine in Alzheimer’s brain, and prevent the progression of Alzheimer’s pathogenesis. Sci Rep 11(1). https://doi.org/10.1038/s41598-021-84640-9
Park MW, Cha HW, Kim J, Kim JH, Yang H, Yoon S, Boonpraman N, Yi SS, Yoo ID, Moon J-S (2021) NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases. Redox Biol 41(101947):101947. https://doi.org/10.1016/j.redox.2021.101947
Pizzino G, Irrera N, Cucinotta M, Pallio G, Mannino F, Arcoraci V, Squadrito F, Altavilla D, Bitto A (2017) Oxidative stress: harms and benefits for human health. Oxid Med Cell Longev 2017:1–13. https://doi.org/10.1155/2017/8416763
Plassman BL, Langa KM, Fisher GG, Heeringa SG, Weir DR, Ofstedal MB, Burke JR, Hurd MD, Potter GG, Rodgers WL, Steffens DC, Willis RJ, Wallace RB (2007) Prevalence of dementia in the United States: the aging, demographics, and memory study. Neuroepidemiology 29(1–2):125–132. https://doi.org/10.1159/000109998
Radzinski M, Oppenheim T, Metanis N, Reichmann D (2021) The cys sense: Thiol redox switches mediate life cycles of cellular proteins. Biomolecules 11(3):469. https://doi.org/10.3390/biom11030469
Rahm F, Viklund J, Trésaugues L, Ellermann M, Giese A, Ericsson U, Forsblom R, Ginman T, Günther J, Hallberg K, Lindström J, Persson LB, Silvander C, Talagas A, Díaz-Sáez L, Fedorov O, Huber KVM, Panagakou I, Siejka P, Andersson M (2018) Creation of a novel class of potent and selective MutT homologue 1 (MTH1) inhibitors using fragment-based screening and structure-based drug design. J Med Chem 61(6):2533–2551. https://doi.org/10.1021/acs.jmedchem.7b01884
Ramesh G, MacLean AG, Philipp MT (2013) Cytokines and chemokines at the crossroads of neuroinflammation, neurodegeneration, and neuropathic pain. Mediators Inflamm 2013:1–20. https://doi.org/10.1155/2013/480739
Ray PD, Huang B-W, Tsuji Y (2012) Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 24(5):981–990. https://doi.org/10.1016/j.cellsig.2012.01.008
Reindl J, Abrantes AM, Ahire V, Azimzadeh O, Baatout S, Baeyens A, Baselet B, Chauhan V, Da Pieve F, Delbart W, Dobney CP (2023) Molecular radiation biology. In Radiobiology textbook. Springer International Publishing
Rougemont M, Do KQ, Castagné V (2002) New model of glutathione deficit during development: effect on lipid peroxidation in the rat brain. J Neurosci Res 70(6):774–783. https://doi.org/10.1002/jnr.10439
Roussos P, Katsel P, Fam P, Tan W, Purohit DP, Haroutunian V (2015) The triggering receptor expressed on myeloid cells 2 (TREM2) is associated with enhanced inflammation, neuropathological lesions and increased risk for Alzheimer’s dementia. Alzheimer’s Dementia: J Alzheimer’s Association 11(10):1163–1170. https://doi.org/10.1016/j.jalz.2014.10.013
Sama MA, Mathis DM, Furman JL, Abdul HM, Artiushin IA, Kraner SD, Norris CM (2008) Interleukin-1β-dependent signaling between astrocytes and neurons depends critically on astrocytic calcineurin/NFAT activity. J Biol Chem 283(32):21953–21964. https://doi.org/10.1074/jbc.m800148200
Schermer MHN, Richard E (2019) On the reconceptualization of Alzheimer’s disease: XXXX. Bioethics 33(1):138–145. https://doi.org/10.1111/bioe.12516
Sebastián-Serrano Á, de Diego-García L, Díaz-Hernández M (2018) The neurotoxic role of extracellular tau protein. Int J Mol Sci 19(4):998. https://doi.org/10.3390/ijms19040998
Selkoe DJ, Hardy J (2016) The amyloid hypothesis of Alzheimer’s disease at 25 years. EMBO Mol Med 8(6):595–608. https://doi.org/10.15252/emmm.201606210
Sen T, Sen N, Jana S, Khan FH, Chatterjee U, Chakrabarti S (2007) Depolarization and cardiolipin depletion in aged rat brain mitochondria: relationship with oxidative stress and electron transport chain activity. Neurochem Int 50(5):719–725. https://doi.org/10.1016/j.neuint.2007.01.007
Shiiba I, Takeda K, Nagashima S, Yanagi S (2020) Overview of mitochondrial E3 ubiquitin ligase MITOL/MARCH5 from molecular mechanisms to diseases. Int J Mol Sci 21(11):3781. https://doi.org/10.3390/ijms21113781
Shimohama S, Tanino H, Kawakami N, Okamura N, Kodama H, Yamaguchi T, Hayakawa T, Nunomura A, Chiba S, Perry G, Smith MA, Fujimoto S (2000) Activation of NADPH oxidase in Alzheimer’s disease brains. Biochem Biophys Res Commun 273(1):5–9. https://doi.org/10.1006/bbrc.2000.2897
Simunkova M, Alwasel SH, Alhazza IM, Jomova K, Kollar V, Rusko M, Valko M (2019) Management of oxidative stress and other pathologies in Alzheimer’s disease. Arch Toxicol 93(9):2491–2513. https://doi.org/10.1007/s00204-019-02538-y
Skoumalová A, Hort J (2012) Blood markers of oxidative stress in A lzheimer’s disease. J Cell Mol Med 16(10):2291–2300
Smith MA (2006) Oxidative stress and iron imbalance in Alzheimer disease: how rust became the fuss! J Alzheimer’s Disease: JAD 9(s3):305–308. https://doi.org/10.3233/jad-2006-9s334
Smith JA, Das A, Ray SK, Banik NL (2012) Role of pro-inflammatory cytokines released from microglia in neurodegenerative diseases. Brain Res Bull 87(1):10–20. https://doi.org/10.1016/j.brainresbull.2011.10.004
Steinert JR, Amal H (2023) The contribution of an imbalanced redox signalling to neurological and neurodegenerative conditions. Free Radic Biol Med 194:71–83. https://doi.org/10.1016/j.freeradbiomed.2022.11.035
Strozyk D, Launer LJ, Adlard PA, Cherny RA, Tsatsanis A, Volitakis I, Blennow K, Petrovitch H, White LR, Bush AI (2009) Zinc and copper modulate Alzheimer Aβ levels in human cerebrospinal fluid. Neurobiol Aging 30(7):1069–1077. https://doi.org/10.1016/j.neurobiolaging.2007.10.012
Tadokoro K, Morihara R, Ohta Y, Hishikawa N, Kawano S, Sasaki R, Matsumoto N, Nomura E, Nakano Y, Takahashi Y, Takemoto M, Yamashita T, Ueno S, Wakutani Y, Takao Y, Morimoto N, Kutoku Y, Sunada Y, Taomoto K, Abe K (2019) Clinical benefits of antioxidative supplement twendee X for mild cognitive impairment: a multicenter, randomized, double-blind, and placebo-controlled prospective interventional study. J Alzheimer’s Disease: JAD 71(3):1063–1069. https://doi.org/10.3233/jad-190644
Takeda K, Uda A, Mitsubori M, Nagashima S, Iwasaki H, Ito N, Shiiba I, Ishido S, Matsuoka M, Inatome R, Yanagi S (2021) Mitochondrial ubiquitin ligase alleviates Alzheimer’s disease pathology via blocking the toxic amyloid-β oligomer generation. Commun Biol 4(1). https://doi.org/10.1038/s42003-021-01720-2
Tavassolifar MJ, Vodjgani M, Salehi Z, Izad M (2020) The influence of reactive oxygen species in the immune system and pathogenesis of multiple sclerosis. Autoimmune Dis 2020:1–14. https://doi.org/10.1155/2020/5793817
Tian Z, Ji X, Liu J (2022) Neuroinflammation in vascular cognitive impairment and dementia: current evidence, advances, and prospects. Int J Mol Sci 23(11). https://doi.org/10.3390/ijms23116224
Ton AM, Campagnaro BP, Alves GA, Aires R, Côco LZ, Arpini CM, Guerra E, Oliveira T, Campos-Toimil M, Meyrelles SS, Pereira TM, Vasquez EC (2020) Oxidative stress and dementia in Alzheimer’s patients: effects of synbiotic supplementation. Oxidative medicine and cellular longevity. Oxid Med Cell Longev
Torac E, Gaman L, Atanasiu V (2014) The regulator of calcineurin (RCAN1) an important factor involved in atherosclerosis and cardiovascular diseases development. J Med Life 7(4):481–487
Toral-Rios D, Pichardo-Rojas PS, Alonso-Vanegas M, Campos-Peña V (2020) GSK3β and tau protein in Alzheimer’s disease and epilepsy. Front Cell Neurosci 14. https://doi.org/10.3389/fncel.2020.00019
Trares K, Chen L-J, Schöttker B (2022) Association of F2-isoprostane levels with Alzheimer’s disease in observational studies: a systematic review and meta-analysis. Ageing Res Rev 74(101552):101552. https://doi.org/10.1016/j.arr.2021.101552
Valavanidis A, Vlachogianni T, Fiotakis C (2009) 8-hydroxy-2′ -deoxyguanosine (8-OHdG): a critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C 27(2):120–139. https://doi.org/10.1080/10590500902885684
Valko M, Leibfritz D, Moncol J, Cronin MTD, Mazur M, Telser J (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39(1):44–84. https://doi.org/10.1016/j.biocel.2006.07.001
van Wijk N, Broersen LM, de Wilde MC, Hageman RJJ, Groenendijk M, Sijben JWC, Kamphuis PJGH (2013) Targeting synaptic dysfunction in Alzheimer’s disease by administering a specific nutrient combination. J Alzheimer’s Disease: JAD 38(3):459–479. https://doi.org/10.3233/jad-130998
Venegas C, Kumar S, Franklin BS, Dierkes T, Brinkschulte R, Tejera D, Vieira-Saecker A, Schwartz S, Santarelli F, Kummer MP, Griep A, Gelpi E, Beilharz M, Riedel D, Golenbock DT, Geyer M, Walter J, Latz E, Heneka MT (2017) Microglia-derived ASC specks cross-seed amyloid-β in Alzheimer’s disease. Nature 552(7685):355–361. https://doi.org/10.1038/nature25158
von Leden RE, Yauger YJ, Khayrullina G, Byrnes KR (2017) Central nervous system injury and nicotinamide adenine dinucleotide phosphate oxidase: oxidative stress and therapeutic targets. J Neurotrauma 34(4):755–764. https://doi.org/10.1089/neu.2016.4486
Wang W-Y, Tan M-S, Yu J-T, Tan L (2015) Role of pro-inflammatory cytokines released from microglia in Alzheimer’s disease. Annals Translational Med 3(10):136. https://doi.org/10.3978/j.issn.2305-5839.2015.03.49
Wang K, Wang L, Chen L, Peng C, Luo B, Mo J, Chen W (2021) Intranasal administration of dauricine loaded on graphene oxide: multi-target therapy for Alzheimer’s disease. Drug Delivery 28(1):580–593. https://doi.org/10.1080/10717544.2021.1895909
Wang L, Fang X, Ling B, Wang F, **a Y, Zhang W, Zhong T, Wang X (2024) Research progress on ferroptosis in the pathogenesis and treatment of neurodegenerative diseases. Front Cell Neurosci 18:1359453. https://doi.org/10.3389/fncel.2024.1359453
Wetterberg H, Najar J, Rydberg Sterner T, Rydén L, Falk Erhag H, Sacuiu S, Kern S, Zettergren A, Skoog I (2023) Decreasing incidence and prevalence of dementia among octogenarians: a population-based study on 3 cohorts born 30 years apart. J Gerontol A 78(6):1069–1077. https://doi.org/10.1093/gerona/glad071
Wimo A, Winblad B, Aguero-Torres H, von Strauss E (2003) The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17(2):63–67. https://doi.org/10.1097/00002093-200304000-00002
Wind S, Beuerlein K, Eucker T, Müller H, Scheurer P, Armitage ME, Ho H, Schmidt H, Wingler K (2010) Comparative pharmacology of chemically distinct NADPH oxidase inhibitors. Br J Pharmacol 161(4):885–898. https://doi.org/10.1111/j.1476-5381.2010.00920.x
Yadav B, Kaur S, Yadav A, Verma H, Kar S, Sahu BK, Pati KR, Sarkar B, Dhiman M, Mantha AK (2024) Implications of organophosphate pesticides on brain cells and their contribution toward progression of Alzheimer’s disease. J Biochem Mol Toxicol 38(3):e23660. https://doi.org/10.1002/jbt.23660
Yan L, Liu S, Wang C, Wang F, Song Y, Yan N, ** S, Liu Z, Sun G (2013) JNK and NADPH oxidase involved in fluoride-induced oxidative stress in BV-2 microglia cells. Mediators Inflamm 2013:1–10. https://doi.org/10.1155/2013/895975
Yang Y, Tan X, Wang Y, Shen B, Yang Y, Huang H (2023) Heteroatom-doped nanozyme progress and perspectives: from synthesis strategies to biomedical applications. Chem Eng J 468:143703. https://doi.org/10.1016/j.cej.2023.143703
Yaribeygi H, Panahi Y, Javadi B, Sahebkar A (2018) The underlying role of oxidative stress in neurodegeneration: a mechanistic review. CNS Neurol Disord Drug Target 17(3):207–215. https://doi.org/10.2174/1871527317666180425122557
Yawalkar MM, Menon S, Swart HC, Dhoble SJ (2022) Fundamentals of photodynamic therapy. In Photophysics and nanophysics in therapeutics. Elsevier
Zhang Y, Kiryu H (2023) Identification of oxidative stress-related genes differentially expressed in Alzheimer’s disease and construction of a hub gene-based diagnostic model. Sci Rep 13(1). https://doi.org/10.1038/s41598-023-34021-1
Zhao J, O’Connor T, Vassar R (2011) The contribution of activated astrocytes to Aβ production: implications for Alzheimer’s disease pathogenesis. J Neuroinflamm 8(1):150. https://doi.org/10.1186/1742-2094-8-150
Zhao J, Shi Q, Zheng Y, Liu Q, He Z, Gao Z, Liu Q (2021) Insights into the mechanism of tyrosine nitration in preventing β-amyloid aggregation in Alzheimer’s disease. Front Mol Neurosci 14. https://doi.org/10.3389/fnmol.2021.619836
Zhong B-R, Zhou G-F, Song L, Wen Q-X, Deng X-J, Ma Y-L, Hu L-T, Chen G-J (2021a) TUFM is involved in Alzheimer’s disease-like pathologies that are associated with ROS. FASEB Journal: Official Publication Federation Am Soc Experimental Biology 35(5):e21445. https://doi.org/10.1096/fj.202002461R
Zhong B-R, Zhou G-F, Song L, Wen Q-X, Deng X-J, Ma Y-L, Hu L-T, Chen G-J (2021b) TUFM is involved in Alzheimer’s disease-like pathologies that are associated with ROS. FASEB J 35(5). https://doi.org/10.1096/fj.202002461r
Zhou M, Cornell J, Salinas S, Huang H-Y (2022) Microglia regulation of synaptic plasticity and learning and memory. Neural Regeneration Res 17(4):705. https://doi.org/10.4103/1673-5374.322423
Zuo J, Zhang Z, Luo M, Zhou L, Nice EC, Zhang W, Wang C, Huang C (2022) Redox signaling at the crossroads of human health and disease. MedComm 3(2):e127. https://doi.org/10.1002/mco2.127
Funding
As this is a review paper, this declaration is not applicable here.
Author information
Authors and Affiliations
Contributions
S.A.K. and A.M. wrote the main manuscript text and prepared the diagrams, and S.M.F. reviewed the manuscript. The authors confirm that no paper mill and artificial intelligence was used.
Corresponding author
Ethics declarations
Ethical approval
The findings of this review manuscript are applicable for both animal and human studies. But as this a review paper, the declaration for consent to participate is not applicable here and the consent to publish solely lies with the authors of this manuscript as this is fully written and reviewed by the authors mentioned earlier.
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Firdous, S.M., Khan, S.A. & Maity, A. Oxidative stress–mediated neuroinflammation in Alzheimer’s disease. Naunyn-Schmiedeberg's Arch Pharmacol (2024). https://doi.org/10.1007/s00210-024-03188-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s00210-024-03188-3